Is Propolis a Potential Anti-Obesogenic Agent for Obesity?
Nilüfer Acar Tek1, Şerife Akpınar Şentüre2, Nursena Ersoy3
1Faculty of Health Science, Department of Nutrition and Dietetic, Gazi University, Emek, Bişkek Main St. 6. St No: 2, 06490, Çankaya, Ankara, Turkey.
Current Nutrition Reports
|March 4, 2024
Summary
Propolis, a natural bee product, aids weight management by boosting energy expenditure. Its polyphenols promote fat tissue browning and activate metabolic pathways, offering a natural strategy against obesity.
Area of Science:
- Bee product research
- Metabolic studies
- Obesity research
Background:
- Propolis, a natural bee-derived resin, possesses a long history of traditional use.
- Its chemical composition and biological activities are geographically variable.
- Modern research investigates propolis for its therapeutic potential.
Purpose of the Study:
- To comprehensively review the structural and biological properties of propolis.
- To explore propolis's potential as a strategy for body weight management.
- To investigate the mechanisms by which propolis influences energy expenditure and fat metabolism.
Main Methods:
- Literature review of scientific studies on propolis.
- Analysis of research on propolis composition and biological activities.
- Examination of studies investigating propolis's effects on thermogenesis and metabolic pathways.
Main Results:
- Propolis polyphenols induce thermogenesis in brown and beige adipose tissue.
- Key phenolic compounds like artepillin C and quercetin exhibit anti-obesogenic effects.
- Mechanisms include sympathetic nervous system stimulation, white adipose tissue browning, and activation of AMP-activated protein kinase (AMPK) and mitochondrial biogenesis.
Conclusions:
- Propolis demonstrates significant potential for body weight management.
- Its compounds effectively increase energy expenditure and combat obesity.
- Propolis offers a promising natural product-based strategy to address the global obesity pandemic.
Related Concept Videos
Obesity
498
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
498
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
175
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
175
Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
Regulation of Food Intake
228
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
228
Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
Hormonal Regulation
43.5K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.5K


